Liquidia Corp
LQDA
96 insider filings · Latest: Oct 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Apr 15 8:43 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 24,733 | $38.71 | $957.4K | — | View → |
| Apr 15, 2026 | Apr 15 8:42 PM | MICHAEL KASETA | Proposed Sale | 139,390 | $38.71 | $5.4M | — | View → |
| Apr 13, 2026 | Apr 14 9:08 PM | Scott MoomawChief Commercial Officer | Sale | 10,547 | $38.34 | $404.4K | 184,558(D) | View → |
| Apr 13, 2026 | Apr 14 9:07 PM | Jason AdairChief Business Officer | Sale | 7,301 | $38.37 | $280.1K | 215,426(D) | View → |
| Apr 13, 2026 | Apr 14 9:07 PM | Dana BoyleChief Accounting Officer | Sale | 5,101 | $38.37 | $195.7K | 176,918(D) | View → |
| Apr 13, 2026 | Apr 14 9:07 PM | Michael KasetaCFO and COO | Sale | 18,958 | $38.37 | $727.4K | 405,775(D) | View → |
| Apr 10, 2026 | Apr 14 9:07 PM | Michael KasetaCFO and COO | Sale | 23,821 | $40.14 | $956.2K | 411,855(D) | View → |
| Apr 13, 2026 | Apr 14 9:06 PM | Sarah KreppChief Human Resource Officer | Sale | 4,557 | $38.37 | $174.9K | 147,019(D) | View → |
| Apr 13, 2026 | Apr 14 9:06 PM | Rajeev SaggarChief Medical Officer | Sale | 9,220 | $38.37 | $353.8K | 173,270(D) | View → |
| Apr 13, 2026 | Apr 14 9:05 PM | Russell SchundlerGeneral Counsel | Sale | 13,692 | $38.37 | $525.4K | 610,532(D) | View → |
| Apr 13, 2026 | Apr 14 9:05 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 32,744 | $38.37 | $1.3M | 1,137,599(D) | View → |
| Apr 10, 2026 | Apr 14 9:05 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 21,433 | $40.12 | $859.9K | 1,495,234(I) | View → |
| Apr 14, 2026 | Apr 14 8:37 PM | MICHAEL KASETA | Proposed Sale | 3,000 | $38.85 | $116.5K | — | View → |
| Apr 9, 2026 | Apr 13 9:47 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.12 | $1.0M | 1,516,667(I) | View → |
| Apr 9, 2026 | Apr 13 9:47 PM | Michael KasetaCFO and COO | Sale | 133,789 | $40.24 | $5.4M | 411,855(D) | View → |
| Apr 10, 2026 | Apr 10 8:35 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $40.32 | $1.0M | — | View → |
| Apr 10, 2026 | Apr 10 8:34 PM | MICHAEL KASETA | Proposed Sale | 23,821 | $40.32 | $960.5K | — | View → |
| Apr 9, 2026 | Apr 9 8:22 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $38.19 | $954.8K | — | View → |
| Apr 9, 2026 | Apr 9 8:21 PM | MICHAEL KASETA | Proposed Sale | 133,789 | $38.19 | $5.1M | — | View → |
| Mar 27, 2026 | Mar 30 9:43 PM | Stephen M BlochDirector | Sale | 62,550 | $35.94 | $2.2M | 2,188,935(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 15 12:01 AM | Scott MoomawChief Commercial Officer | Option Exercise | 7,466 | — | 43,580(D) | View → |
| Jul 10, 2026 | Jul 14 11:59 PM | Dana BoyleChief Accounting Officer | Option Exercise | 3,179 | — | 31,787(D) | View → |
| May 21, 2026 | May 26 10:17 PM | Raman SinghDirector | Option Exercise | 29,494 | $11.00 | 0(D) | View → |
| Apr 15, 2026 | Apr 17 12:37 AM | Michael KasetaCFO and COO | Option Exercise | 86,971 | $2.79 | 10,534(D) | View → |
| Apr 14, 2026 | Apr 17 12:37 AM | Michael KasetaCFO and COO | Option Exercise | 3,000 | $2.79 | 97,505(D) | View → |
| Apr 10, 2026 | Apr 14 9:08 PM | Scott MoomawChief Commercial Officer | Option Exercise | 7,465 | — | 47,938(D) | View → |
| Apr 10, 2026 | Apr 14 9:07 PM | Jason AdairChief Business Officer | Option Exercise | 10,248 | — | 42,553(D) | View → |
| Apr 10, 2026 | Apr 14 9:07 PM | Dana BoyleChief Accounting Officer | Option Exercise | 3,179 | — | 34,966(D) | View → |
| Apr 10, 2026 | Apr 14 9:07 PM | Michael KasetaCFO and COO | Option Exercise | 36,699 | $2.79 | 77,547(D) | View → |
| Apr 10, 2026 | Apr 14 9:06 PM | Sarah KreppChief Human Resource Officer | Option Exercise | 3,179 | — | 34,966(D) | View → |
| Apr 10, 2026 | Apr 14 9:06 PM | Rajeev SaggarChief Medical Officer | Option Exercise | 8,017 | — | 49,349(D) | View → |
| Apr 10, 2026 | Apr 14 9:05 PM | Russell SchundlerGeneral Counsel | Option Exercise | 10,167 | — | 70,498(D) | View → |
| Apr 10, 2026 | Apr 14 9:05 PM | Roger JeffsDirector, Chief Executive Officer | Option Exercise | 28,167 | — | 157,662(D) | View → |
| Apr 9, 2026 | Apr 13 9:47 PM | Michael KasetaCFO and COO | Option Exercise | 133,789 | $2.97 | 0(D) | View → |
| Mar 23, 2026 | Mar 25 8:30 PM | Scott MoomawChief Commercial Officer | Option Exercise | 17,000 | $3.40 | 8,300(D) | View → |
| Mar 13, 2026 | Mar 17 8:30 PM | Raman SinghDirector | Option Exercise | 20,000 | $4.86 | 0(D) | View → |
| Mar 9, 2026 | Mar 11 8:30 PM | Scott MoomawChief Commercial Officer | Option Exercise | 80,000 | $3.40 | 25,300(D) | View → |
| Feb 27, 2026 | Mar 3 9:34 PM | Russell SchundlerGeneral Counsel | Option Exercise | 2,344 | — | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:33 PM | Scott MoomawChief Commercial Officer | Option Exercise | 1,875 | — | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:31 PM | Michael KasetaCFO and COO | Option Exercise | 2,344 | — | 0(D) | View → |